Related Experiment Video
Updated: Jul 14, 2026

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis
M T Abdel Aziz1, H M Atta, S Mahfouz
1Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Eqypt. talaatbdaziz@yahoo.co.uk
Objective:
To study the effect of mesenchymal stem cells (MSC) on experimental liver fibrosis in rats.
Design And Method:
MSC were derived from bone marrow obtained from femoral and tibial bones of male albino rats. MSC were separated, grown, and propagated in culture for 4 weeks and were characterized morphologically and by detection of CD29 by RT-PCR. They were then infused into the tail vein of female rats that received CCl4 injection to induce liver fibrosis. Rats were divided into 4 groups: control, CCl4, CCl4 plus MSC, and MSC. Liver tissue was examined histopathologically and liver functions (ALT and serum albumin) were estimated for all groups. Y-chromosome gene (sry) was assessed by PCR in liver tissue of the female rats to confirm uptake of the male stem cells. Hydroxyproline content in liver tissue was assessed by chemical methods and expression of the collagen gene (type I) was detected as a marker for liver fibrosis. Results of the present study showed that MSC have a significant antifibrotic effect as evidenced by the significant decrease in liver collagen gene expression as well as the decrease in hydroxyproline content in the CCl4/MSC group (p<0.001) compared to the CCl4 group. The Y-chromosome gene (sry) was detected by RT-PCR in the CCl4/MSC group, but was not detected in control group and other groups. The CD29 gene was expressed in MSC culture, and this confirmed the efficiency of isolation and propagation of MSC in culture. With regard to liver function, there was also a significant improvement and elevation of serum albumin in the CCl4/MSC group compared to the CCl4 group (p<0.05). As regard to the liver enzyme ALT, there was a decrease of its level in the CCl4/MSC group compared to the CCl4 group. However, this was statistically nonsignificant (p>0.05). In conclusion, MSC have a potential therapeutic effect against the fibrotic process through their effect in minimizing collagen deposition in addition to their capacity to differentiate into hepatocytes.
Insights
Mesenchymal stem cells (MSC) show significant therapeutic potential against liver fibrosis in rats. MSC treatment reduced collagen deposition and improved liver function, indicating a promising antifibrotic effect.
Area of Science:
- Stem cell research
- Hepatology
- Fibrosis research
Background:
- Liver fibrosis is a chronic condition characterized by excessive collagen deposition.
- Mesenchymal stem cells (MSC) are being investigated for their regenerative and immunomodulatory properties.
Purpose of the Study:
- To evaluate the therapeutic efficacy of MSC in an experimental model of liver fibrosis in rats.
- To assess the impact of MSC on collagen deposition, liver function markers, and potential differentiation into hepatocytes.
Main Methods:
- Mesenchymal stem cells (MSC) were isolated from rat bone marrow and characterized.
- Liver fibrosis was induced in female rats using CCl4 injection.
- Rats received tail vein infusions of MSC, and various parameters including histopathology, liver function tests (ALT, albumin), hydroxyproline content, and gene expression (collagen, sry) were analyzed.
Main Results:
- MSC treatment significantly reduced liver collagen gene expression and hydroxyproline content in fibrotic rats (p<0.001).
- A significant improvement in serum albumin levels was observed in the MSC-treated group (p<0.05).
- The Y-chromosome gene (sry) was detected in the liver of female rats treated with male MSC, suggesting cell engraftment.
Conclusions:
- Mesenchymal stem cells (MSC) demonstrate a significant antifibrotic effect in experimental liver fibrosis.
- MSC therapy can minimize collagen deposition and potentially differentiate into hepatocytes, offering therapeutic benefits.
- MSC represent a promising therapeutic strategy for managing liver fibrosis.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
